Medlab Clinical $6.600
(0.00%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 4:01am | ||||
MEDLAB CLINICAL LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
Biotech Investors' Conference Presentation
MDC released this announcement to the ASX on 17 August 2022, 15:25. The announcement is not marked as price sensitive, and is 21 page(s) in length and 11.55MB in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Biotech Investors' Conference Presentation | 17 August 2022, 15:25 |
| Depression European Patent Accepted, Proceeding to Grant | 10 August 2022, 10:12 |
| Initial Director's Interest Notice | 8 August 2022, 9:12 |
| Leading Healthcare Executive joins Medlab Board | 8 August 2022, 9:12 |
If you were already registered, log in here.
If you were already registered, log in here.